SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

The QQQ is trending amid intense investor anxiety over the collapse of U.S.-Iran peace talks and a subsequent announcement by the U.S. Navy to initiate a blockade of the Strait of Hormuz. Community discourse is highly polarized, with market participants debating whether this geopolitical escalation will trigger a significant sell-off or if the prevailing bullish momentum will allow the index to shrug off the worsening macro instability.

RaveDAO is a global community uniting music, technology, and purpose. Since their first sold-out event at Dubai 2024, they have expanded across Europe, the Middle East, North America, and Asia, hosting world-class experiences with over 100,000 total attendees and 3,000+ attendees for each event.  RaveDAO has worked with top-tier artists like Vintage Culture, Don Diablo, Chris Avantgarde, Lilly Palmer, MORTEN, Bassjackers, and GENESI and has support from Binance, OKX, Bitget, and Polygon. RaveDAO is redefining live entertainment in Web3 and has active partnerships with 1001Tracklists, AMF, and Warner Music.  Beyond the dance floor, RaveDAO channels energy and attention toward impact. In 2025 alone, proceeds from its events helped restore sight to 400+ cataract patients in Nepal and fund over 150 meditation programs across the U.S.

RaveDAO

RaveDAO is drawing significant investor attention as it hits record highs, fueled by intense social media hype, speculative partnership rumors, and a recent listing collaboration with World Liberty Financial. While some traders are celebrating the rapid price momentum and the potential for a massive breakout, others are debating whether the current valuation is sustainable or if the asset is experiencing a speculative pump-and-dump cycle.

SPDR S&P 500 ETF TRUST - SPDR S&P 500 ETF Trust

Market sentiment for the S&P 500 is currently dominated by intense volatility and geopolitical uncertainty, specifically regarding a planned U.S. naval blockade of the Strait of Hormuz following stalled peace negotiations with Iran. Investors are actively debating the potential for a major market pullback versus the possibility of sudden, news-driven "Taco" pump reversals as they monitor oil prices and upcoming earnings reports.

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflix is trending following a bullish upgrade from Goldman Sachs, which raised its price target to $120 and cited renewed growth momentum in advertising and subscription scaling. Investors are actively debating the stock's ability to maintain these gains ahead of its upcoming earnings report, with many looking for a breakout above the $100 level as a key signal for further momentum.

Bitcoin is the world's first decentralized cryptocurrency, created in 2009 by the pseudonymous Satoshi Nakamoto. It enables peer-to-peer electronic cash transactions without intermediaries like banks or governments, operating on a blockchain secured by Proof of Work mining and the SHA-256 cryptographic algorithm.   With a fixed supply cap of 21 million coins and programmatic halvings every four years that reduce miner rewards, Bitcoin is designed as a deflationary digital asset often called "digital gold." Its value stems from solving the double-spending problem without trusted intermediaries, creating the first truly scarce digital asset with censorship resistance and permissionless access that no government, corporation, or individual can control.  Bitcoin operates as a decentralized peer-to-peer network where transactions are recorded on a public ledger called the blockchain, distributed across thousands of computers globally. Transactions are grouped into blocks added approximately every 10 minutes through mining, where specialized computers compete to solve complex mathematical puzzles.   Bitcoin has achieved mainstream adoption through multiple vectors. The January 2024 SEC approval of 11 spot Bitcoin ETFs opened Bitcoin investment to traditional finance participants, and corporations like Strategy (formerly MicroStrategy) are using Bitcoin as a treasury reserve asset to protect against currency debasement, offering MSTR holders amplified exposure to Bitcoin.   The Bitcoin ecosystem continues to evolve with innovations like Ordinals, which emerged in January 2023 to enable NFT-like functionality directly on Bitcoin, and BRC-20 tokens, an experimental standard for creating fungible tokens using Ordinal inscriptions. BTCFi (Bitcoin Finance) represents emerging financial applications extending beyond Bitcoin's traditional role, with protocols like Babylon allowing Bitcoin holders to stake BTC to secure Proof of Stake chains.

Bitcoin

Bitcoin is experiencing heightened volatility and speculative trading as traders react to the collapse of high-stakes diplomatic negotiations regarding the Strait of Hormuz. While some community members remain focused on long-term institutional accumulation and supply-side fundamentals, many are actively debating the potential for a short-term breakdown if geopolitical tensions and rising energy costs trigger a broader market correction.

FIGHT

The community is rallying around FIGHT, citing a perceived connection to UFC branding and strong speculative interest in its potential to replicate the viral growth seen in major meme coins. Traders are actively debating the token's market positioning while identifying it as a high-conviction play against traditional financial systems.

Back in 2011, long before “crypto Twitter”, NFTs, or VC-backed chains existed, users of the BitcoinTalk forum came up with a new currency - not to launch a network, but to make fun of btc.... and so: The first memecoin/memecurrency was born.  On May 23, 2011, a Something Awful poster cracked, “Has anyone called them buttcoins yet?”. It was sophomoric and perfect. Within weeks the gag metastasized into Buttcoin.org, a parody blog that described a “peer to peer butt” economy while cataloging mining fiascos, exchange blowups, and MLM-adjacent “innovations”.

Buttcoin

Buttcoin is trending as the community embraces its status as a historic parody of Bitcoin, with supporters highlighting its 2011 origins and lore as a "store of butts" to differentiate it from newer, less-established memecoins. The conversation centers on long-term conviction, with holders actively debating its potential to flip Bitcoin or achieve significant market cap growth while dismissing criticisms as a sign of early-stage skepticism.

Maulcoin

Maulcoin is surging in community sentiment as investors rally around the project's organic growth and the promise of a forthcoming coin chart and wallet airdrops. The community is actively promoting a diamond-hand, long-term holding strategy to drive the token toward higher market milestones while dismissing short-term volatility.

United States Oil Fund LP - United States Oil Fund

United States Oil Fund

The United States Oil Fund (USO) is highly volatile as traders react to the collapse of high-level peace talks in Islamabad between the U.S. and Iran. The community remains deeply divided, with discussions centered on the strategic implications of a potential Strait of Hormuz blockade, ongoing military operations, and speculative theories regarding government market manipulation and the long-term impact on global energy prices.

VS Trust - 2x Long VIX Futures ETF

Volatility Shares 2x Long VIX Futures ETF

UVIX is experiencing intense community focus as traders speculate on the impact of a potential military escalation and the ongoing closure of the Strait of Hormuz, with many arguing that volatility products are being artificially suppressed by headline-driven political messaging. Participants are heavily divided, with some betting on a massive spike in market instability due to high oil prices and geopolitical risk, while others warn of the inherent structural decay associated with leveraged volatility ETFs.

statis crypto Watchlist

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Olema Pharmaceuticals (NASDAQ:OLMA) Raised to "Sell" at Wall Street Zen

Wall Street Zen upgraded shares of Olema Pharmaceuticals from a "strong sell" rating to a "sell" rating in a research note on Saturday...

Olema Pharmaceuticals (NASDAQ:OLMA) Trading 7.7% Higher - Here's What Happened

Olema Pharmaceuticals (NASDAQ:OLMA) Stock Price Up 7.7% - What's Next...

SG Americas Securities LLC Purchases Shares of 69,382 Olema Pharmaceuticals, Inc. $OLMA

SG Americas Securities LLC bought a new stake in shares of Olema Pharmaceuticals, Inc. (NASDAQ:OLMA - Free Report) in the fourth quarter, according to the company in its most recent 13F filing with...

Olema Pharmaceuticals (NASDAQ:OLMA) Shares Up 8.4%  - Still a Buy?

Olema Pharmaceuticals (NASDAQ:OLMA) Shares Up 8.4% - Here's Why...

Hennion & Walsh Asset Management Inc. Increases Position in Olema Pharmaceuticals, Inc. $OLMA

Hennion & Walsh Asset Management Inc. increased its holdings in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA - Free Report) by 83.2% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 447,046 shares of the company's stock after purchas...

Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Receives Consensus Rating of "Moderate Buy" from Analysts

Shares of Olema Pharmaceuticals, Inc. (NASDAQ:OLMA - Get Free Report) have been given an average rating of "Moderate Buy" by the fourteen analysts that are currently covering the stock, Marketbeat.com reports. One equities research analyst has rated the stock with a sell rating, two have given a h...

Wolfe Research Initiates Coverage on Olema Pharmaceuticals (NASDAQ:OLMA)

Wolfe Research started coverage on shares of Olema Pharmaceuticals in a research report on Friday. They issued a "peer perform" rating for the company...

Olema Stock Up 242%, but Does a $122 Million Position Suggest More Upside Potential?

Key PointsParadigm Biocapital Advisor increased its stake in Olema Pharmaceuticals by 750,000 shares in Q4 2025...

Jefferies Financial Group Begins Coverage on Olema Pharmaceuticals (NASDAQ:OLMA)

Jefferies Financial Group assumed coverage on Olema Pharmaceuticals in a report on Thursday. They issued a "buy" rating for the company...

Olema Pharmaceuticals (NASDAQ:OLMA) Stock Price Expected to Rise, JPMorgan Chase & Co. Analyst Says

JPMorgan Chase & Co. lifted their target price on Olema Pharmaceuticals from $55.00 to $58.00 and gave the company an "overweight" rating in a research note on Wednesday...

Olema Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovery, development, and commercialization of next generation targeted therapies for women’s cancers. Its product candidate, OP-1250, is a novel oral therapy with combined activity as both a complete ER antagonist, or CERAN, and a selective ER degrader, or SERD, which is believed to drive deeper, more durable responses than existing therapies. The company was founded by Cyrus L. Harmon and Peter J. Kushner on August 7, 2006 and is headquartered in San Francisco, CA.

Fiscal Period	Estimated	Reported	Surprise	Result
Q1 '26	-$0.53	--	--	N/A
Q4 '25	-$0.51	-$0.50	2.73%	BEAT
Q3 '25	-$0.47	-$0.49	-3.24%	MISSED
Q2 '25	-$0.42	-$0.51	-20.50%	MISSED
Q1 '25	-$0.49	-$0.36	25.77%	BEAT

OLMA
Olema Pharmaceuticals Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest Earnings Results: Q4 '25

Historical Earnings

Latest OLMA News

OLMAOlema Pharmaceuticals Inc